[IKT] QoQ Quarter Result on 30-Jun-2020 [#Q2]

Stock
[IKT] Inhibikase Therapeutics, Inc.
Announcement Date
29-Jun-2020
Financial Year
2020
Quarter
30-Jun-2020 [#Q2]
Profit Trend
QoQ- 22.85%
YoY- 82.00%
Quarter Report
IKT's Result
IKT's Financial Summary
View:
Show?
Quarter Result
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
Revenue 1,407 698 38 220 271 240 124 404.20%
PBT -2,637 -1,208 -671 -422 -547 -430 -1,212 67.82%
Tax -2,625 -2,841 -664 -414 -540 -422 -1,205 67.96%
NP -2,637 -1,208 -671 -422 -547 -430 -1,212 67.82%
Tax Rate - - - - - - - -
Total Cost 4,044 1,906 708 641 818 670 1,337 109.00%
Ratio Analysis
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
NP Margin -187.40 -172.95 -1,779.72 -192.12 -202.17 -178.97 -974.37 -66.64%
Per Share
31/03/21 31/12/20 30/09/20 30/06/20 31/03/20 31/12/19 30/09/19 CAGR
EPS -1.57 -0.87 -0.49 -0.31 -0.40 -0.32 -0.89 45.94%
EPS Diluted -1.57 -0.87 -0.49 -0.31 -0.40 -0.32 -0.89 45.94%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.